title: [VI. Improvement of combined modality therapy for pancreas cancer].
authors: Hideyuki
authors: H
authors: Yoshitomi
authors: Hiroaki
authors: H
authors: Shimizu
authors: Masayuki
authors: M
authors: Otshuka
authors: Atsushi
authors: A
authors: Kato
authors: Katsunori
authors: K
authors: Furukawa
authors: Tsukasa
authors: T
authors: Takayashiki
authors: Tomo
authors: T
authors: Kuboki
authors: Daiki
authors: D
authors: Okamura
authors: Hiroaki
authors: H
authors: Suzuki
authors: Nozomu
authors: N
authors: Sakai
authors: Masayuki
authors: M
authors: Nakajima
authors: Masaru
authors: M
authors: Miyazaki
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D018450:Disease Progression; D006801:Humans; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents